Swimmer plot depicting clinical outcomes after pembrolizumab. Bars are color coded based on 3-month response. Best ORR and 3-month ORR was 3 of 12 (25%). One patient had a CR (light blue bar), and 2 patients had PRs (light green bars). Two patients had SD with symptomatic improvement as best response, but only 1 of these patients continued to maintain SD at 3 months (yellow bar) and the other patient had PD at 3 months (red bar). The remaining 7 patients had progression of lymphoma (red bars). Orange triangles, onset of CR; green triangles, onset of PR; lavender triangles, onset of SD; black arrows, patient is alive at last follow-up; steel blue circles, patient is deceased. Response to CAR T cells (eg, relapsed or refractory) is indicated after patient ID number.